Paul Manning

Paul B. Manning is the founder.
Mr. Manning was the founder of PBM Products LLC, serving as President & Chief Executive Officer since 1997.
Mr. Manning is the founder of PBM Capital Group LLC, serving as Chairman and CEO since 2010.
Mr. Manning is also the founder of Able Laboratories, Inc. Mr. Manning serves as President & Chief Executive Officer at PBM Capital Investments LLC.
Mr. Manning serves as Chairman at Candel Therapeutics, Inc. since 2021.
Mr. Manning serves as Chairman at Xalud Therapeutics, Inc. Mr. Manning serves as Chairman at Verrica Pharmaceuticals, Inc. since 2017.
Mr. Manning serves as Director at PatientsLikeMe LLC since 2022.
Mr. Manning serves as Director at The Foundation Fighting Blindness, Inc. Mr. Manning serves as Director at Foundation Fighting Blindness Clinical Research Institute.
Mr. Manning serves as Director at PBM Pharmaceuticals, Inc. Mr. Manning serves as Independent Director at ArcherDX LLC since 2015.
Mr. Manning serves as Director at Tolerion, Inc. Mr. Manning serves as Director at UVA Health Foundation.
Mr. Manning serves as Independent Director at Liquidia Corp.
since 2020.
Former positions include Chairman at Dova Pharmaceuticals, Inc. from 2017 to 2019.
Director at QIAGEN Beverly LLC.
Director at Gen9, Inc. Director at Advanz Pharma Corp.
Ltd. from 2014 to 2015.
Independent Director at Novartis Gene Therapies, Inc. from 2014 to 2018.
Independent Director at Taysha Gene Therapies, Inc. from 2020 to 2023.
Director at Liquidia PAH LLC from 2018 to 2020.
Executive Vice President & General Manager at Perrigo Co. from 2010 to 2014.
Principal at Beta-Pro LLC.
Education includes an undergraduate degree from the University of Massachusetts.